Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potential Benefit for Non Invasive Vagus Nerve Stimulation (nVNS) Using GammaCore in the Treatment of Raynaud's Phenomena.

NCT03869008 is registered in ClinicalTrials.gov with University of Toledo Health Science Campus as lead sponsor.

NCT NCT03869008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03869008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potential Benefit for Non Invasive Vagus Nerve Stimulation (nVNS) Using GammaCore in the Treatment of Raynaud's Phenomena.
Lead sponsor
University of Toledo Health Science Campus
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2019
Completion date
February 27, 2020
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary raynaud phenomenon, raynaud disease, raynaud phenomenon, raynaud syndrome